The Liberty surgical robot is a single-use endovascular system and requires no dedicated infrastructure to be used.

Microbot Medical is adding a U.S.-based clinical research associate to support its IDE submission to commence its first-in-human clinical trial. 

Microbot Medical has completed a pivotal pre-clinical study of its Liberty endovascular robotic surgical system.

Microbot Medical raised nearly $9 million in a common stock offering. This comes just days after announcing it is set to unveil its disposable robotic system for multiple procedures later this month. The Hingham, Mass.–based company agreed to sell 900,901 shares of common stock at a purchase price of $11.10 per share. The gross proceeds…